Neuralstem Gains on Stem Cell Therapy for Paralyzed RatsRyan Flinn
Neuralstem Inc., a biotechnology company with no approved products, gained the most ever after saying its stem cell treatment restored paralyzed rats’ ability to move in an early study.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.
- This $14 Million Atlanta Home With Bunker Is ‘Safest in America’
- GE's New CEO Vows Sweeping Change After ‘Unacceptable’ Report
- These Cities Make NYC Housing Look Dirt Cheap
- Separatists Pledge to Fight On After Spain Moves to Oust Catalan Leaders
- The U.K.'s $86 Billion Pension Problem Is About to Solve Itself